Efficacy and Safety Study of Elagolix in Women With Endometriosis

• Status: Completed
• Trial end date: 2010-09-22

Summary

The purpose of this study is to evaluate elagolix (NBI-56418) compared to placebo for its effects on endometriosis related pelvic pain and its safety.

• Phase: Phase 2

Details

• Lead Sponsor: AbbVie; AbbVie (prior sponsor, Abbott)